Wilke RA - Search Results

1

High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.

Wilke RA. Wilke RA. Pharmacogenomics J. 2011 Jun;11(3):162-73. doi: 10.1038/tpj.2010.86. Epub 2010 Dec 14. Pharmacogenomics J. 2011. PMID: 21151197 Free PMC article. Review.

2

Mapping genes that predict treatment outcome in admixed populations.

Baye TM, Wilke RA. Baye TM, et al. Among authors: wilke ra. Pharmacogenomics J. 2010 Dec;10(6):465-77. doi: 10.1038/tpj.2010.71. Epub 2010 Oct 5. Pharmacogenomics J. 2010. PMID: 20921971 Free PMC article.

3

Genetic variation in the UGT1A locus is associated with simvastatin efficacy in a clinical practice setting.

Iwuchukwu OF, Feng Q, Wei WQ, Jiang L, Jiang M, Xu H, Denny JC, Wilke RA, Krauss RM, Roden DM, Stein CM. Iwuchukwu OF, et al. Among authors: wilke ra. Pharmacogenomics. 2014 Nov;15(14):1739-1747. doi: 10.2217/pgs.14.128. Pharmacogenomics. 2014. PMID: 25493567 Free PMC article.

4

Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

Oetjens MT, Denny JC, Ritchie MD, Gillani NB, Richardson DM, Restrepo NA, Pulley JM, Dilks HH, Basford MA, Bowton E, Masys DR, Wilke RA, Roden DM, Crawford DC. Oetjens MT, et al. Among authors: wilke ra. Pharmacogenomics. 2013 May;14(7):735-44. doi: 10.2217/pgs.13.64. Pharmacogenomics. 2013. PMID: 23651022 Free PMC article.

5

CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.

White CC, Feng Q, Cupples LA, Gainer JV, Dawson EP, Wilke RA, Brown NJ. White CC, et al. Among authors: wilke ra. Pharmacogenomics J. 2013 Feb;13(1):44-51. doi: 10.1038/tpj.2011.40. Epub 2011 Sep 13. Pharmacogenomics J. 2013. PMID: 21912424 Free PMC article.

6

Knowledge-driven multi-locus analysis reveals gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked biobanks.

Turner SD, Berg RL, Linneman JG, Peissig PL, Crawford DC, Denny JC, Roden DM, McCarty CA, Ritchie MD, Wilke RA. Turner SD, et al. Among authors: wilke ra. PLoS One. 2011 May 11;6(5):e19586. doi: 10.1371/journal.pone.0019586. PLoS One. 2011. PMID: 21589926 Free PMC article.

7

Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Feng Q, Wilke RA, Baye TM. Feng Q, et al. Among authors: wilke ra. Pharmacogenomics. 2012 Apr;13(5):579-94. doi: 10.2217/pgs.12.11. Pharmacogenomics. 2012. PMID: 22462750 Free PMC article. Review.

8

Pacific Symposium on Biocomputing--computational approaches for pharmacogenomics.

Wilke RA, Carrillo MW, Ritchie MD. Wilke RA, et al. Pharmacogenomics. 2005 Mar;6(2):111-3. doi: 10.1517/14622416.6.2.111. Pharmacogenomics. 2005. PMID: 15882130 Free article. No abstract available.

9

Biobanking and pharmacogenomics.

McCarty CA, Wilke RA. McCarty CA, et al. Among authors: wilke ra. Pharmacogenomics. 2010 May;11(5):637-41. doi: 10.2217/pgs.10.13. Pharmacogenomics. 2010. PMID: 20415552 Free article. Review.

10

The emerging role of electronic medical records in pharmacogenomics.

Wilke RA, Xu H, Denny JC, Roden DM, Krauss RM, McCarty CA, Davis RL, Skaar T, Lamba J, Savova G. Wilke RA, et al. Clin Pharmacol Ther. 2011 Mar;89(3):379-86. doi: 10.1038/clpt.2010.260. Epub 2011 Jan 19. Clin Pharmacol Ther. 2011. PMID: 21248726 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page